Partnership

Homepage - Torlak Institute

Messenger Biopharma has established a partnership with the Torlak Institute for the development of an mRNA vaccine against the West Nile Virus.

Last news

Vaccines Glimpses (1)-1

Jérôme Lemoine was a plenary speaker at the 4th International…

posted January 30, 2026

He presented Messenger Biopharma’s capless ...Read More

Recent Search Keywords